Go to Content Go to Menu

Scientific Publications

 

2022

  1. Bezzerri V, Lentini L, Api M, Busilacchi EM, Cavalieri V, Pomilio A, Diomede F, Pegoraro A, Cesaro S, Poloni A, Pace A, Trubiani O, Lippi G, Pibiri I, Cipolli M.
    Novel Translational Read-through-Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome. Biomedicines.
    2022 Apr 12;10(4):886. doi: 10.3390/biomedicines10040886. PMID:35453634.
  2. Campagna G, Amato A, Majo F, Ferrari G, Quattrucci S, Padoan R, Floridia G, Salvatore D, Carnovale V, Puppo Fornaro G, Taruscio D, Salvatore M; Gruppo di lavoro RIFC.
    [Italian Cystic Fibrosis Registry (ICFR). Report 2019-2020].
    Epidemiol Prev. 2022 Jul-Aug;46(4 Suppl 2):1-38. doi: 10.19191/EP22.4S2.060.PMID:36102313.
  3. Cesaro S, Donadieu J, Cipolli M, Dalle JH, Styczynski J, Masetti R, Strahm B, Mauro M, Alseraihy A, Aljurf M, Dufour C, de la Tour RP.
    Stem Cell Transplantation in Patients Affected by Shwachman-Diamond Syndrome: Expert Consensus and Recommendations From the EBMT Severe Aplastic Anaemia Working Party. Transplant Cell Ther.
    2022 Oct;28(10):637-649. doi: 10.1016/j.jtct.2022.07.010. Epub 2022 Jul 20.PMID:35870777.
  4. Ciciriello F, Bijvelds MJC, Alghisi F, Meijsen KF, Cristiani L, Sorio C, Melotti P, Fiocchi AG, Lucidi V, De Jonge HR.
    Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers.
    J Pers Med. 2022 Apr 14;12(4):632. doi: 10.3390/jpm12040632.PMID:35455747.
  5. Ciet P, Bertolo S, Ros M, Casciaro R, Cipolli M, Colagrande S, Costa S, Galici V, Gramegna A, Lanza C, Lucca F, Macconi L, Majo F, Paciaroni A, Parisi GF, Rizzo F, Salamone I, Santangelo T, Scudeller L, Saba L, Tomà P, Morana G.
    State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium.
    Eur Respir Rev. 2022 Mar 23;31(163):210173. doi: 10.1183/16000617.0173-2021. Print 2022 Mar 31.PMID:35321929.
  6. Colombo C, Cipolli M, Daccò V, Medino P, Alghisi F, Ambroni M, Badolato R, Battistini F, Bignamini E, Casciaro R, Ciciriello F, Collura M, Comello I, Francalanci M, Ficili F, Folino A, Leonardi S, Leonetti G, Lucanto MC, Lucca F, Maschio M, Mencarini V, Messore B, Pisi G, Pizzamiglio G, Poli P, Raia V, Riberi L, Ros M, Rotolo N, Sepe A, Taccetti G, Vitullo P, Alicandro G.
    Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society. Infection.
    2022 Jun;50(3):671-679. doi: 10.1007/s15010-021-01737-z. Epub 2021 Dec 7.PMID:34874541.
  7. Costa E, Girotti S, Pauro F, Leufkens HGM, Cipolli M.
    The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis.
    Orphanet J Rare Dis. 2022 May 7;17(1):188. doi: 10.1186/s13023-022-02350-5.PMID:35525974.
  8. Dal Ben S, Gaudino R, Cavarzere P, Volpi S, Antoniazzi F, Boner A, Piacentini G.
    Age at menarche in girls with cystic fibrosis and asthma.
    Minerva Endocrinol (Torino). 2022 Dec;47(4):479-481. doi: 10.23736/S2724-6507.21.03451-5. Epub 2022 Feb 23.
  9. Ghigo A, Murabito A, Sala V, Pisano AR, Bertolini S, Gianotti A, Caci E, Montresor A, Premchandar A, Pirozzi F, Ren K, Della Sala A, Mergiotti M, Richter W, de Poel E, Matthey M, Caldrer S, Cardone RA, Civiletti F, Costamagna A, Quinney NL, Butnarasu C, Visentin S, Ruggiero MR, Baroni S, Crich SG, Ramel D, Laffargue M, Tocchetti CG, Levi R, Conti M, Lu XY, Melotti P, Sorio C, De Rose V, Facchinetti F, Fanelli V, Wenzel D, Fleischmann BK, Mall MA, Beekman J, Laudanna C, Gentzsch M, Lukacs GL, Pedemonte N, Hirsch E.
    A PI3Ky mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases.
    Sci Transl Med. 2022 Mar 30;14(638):eabl6328. doi: 10.1126/scitranslmed.abl6328. Epub 2022 Mar 30.PMID:35353541.
  10. Medino P, Alicandro G, Rosazza C, Ciciriello F, Gramegna A, Biffi A, Daccò V, Lucidi V, Cipolli M, Boraso M, Nazzari E, Colombo C.
    Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes.
    Biomedicines. 2022 Nov 1;10(11):2771. doi: 10.3390/biomedicines10112771.
  11. Piona C, Mozzillo E, Tosco A, Volpi S, Rosanio FM, Cimbalo C, Franzese A, Raia V, Zusi C, Emiliani F, Boselli ML, Trombetta M, Bonadonna RC, Cipolli M, Maffeis C.
    Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis.
    J Clin Med. 2022 Jul 17;11(14):4149. doi: 10.3390/jcm11144149.PMID:35887914.
  12. Sandri A, Veschetti L, Saitta GM, Passarelli Mantovani R, Carelli M, Burlacchini G, Preato S, Sorio C, Melotti P, Montemari AL, Fiscarelli EV, Patuzzo C, Signoretto C, Boaretti M, Lleò MM, Malerba G.
    Achromobacter spp. Adaptation in Cystic Fibrosis Infection and Candidate Biomarkers of Antimicrobial Resistance.
    Int J Mol Sci. 2022 Aug 17;23(16):9265. doi: 10.3390/ijms23169265.PMID:36012535.
  13. Sermet-Gaudelus I, Girodon E, Vermeulen F, Solomon GM, Melotti P, Graeber SY, Bronsveld I, Rowe SM, Wilschanski M, Tümmler B, Cutting GR, Gonska T.
    ECFS standards of care on CFTR-related disorders: Diagnostic criteria of CFTR dysfunction.
    J Cyst Fibros. 2022 Nov;21(6):922-936. doi: 10.1016/j.jcf.2022.09.005. Epub 2022 Oct 5.PMID:36207272.
  14. Taha I, De Paoli F, Foroni S, Zucca S, Limongelli I,Cipolli M, Danesino C, Ramenghi U, Minelli A.
    Phenotypic Variation in Two Siblings Affected with Shwachman-Diamond Syndrome: The Use of Expert Variant Interpreter (eVai) Suggests Clinical Relevance of a Variant in the KMT2A Gene.
    Genes (Basel). 2022 Jul 23;13(8):1314. doi: 10.3390/genes13081314.PMID:35893049.
  15. Taha I, Foroni S, Valli R, Frattini A, Roccia P, Porta G, Zecca M, Bergami E,Cipolli M, Pasquali F, Danesino C, Scotti C, Minelli A.
    Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman-Diamond Syndrome.
    Front Genet. 2022 Aug 12;13:896749. doi: 10.3389/fgene.2022.896749. eCollection 2022.PMID:36035165.
  16. Tiddens HAWM, Chen Y, Andrinopoulou ER, Davis SD, Rosenfeld M, Ratjen F, Kronmal RA, Hinckley Stukovsky KD, Dasiewicz A, Stick SM; SHIP-CT Study Group.
    The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial.
    Lancet Respir Med. 2022 Jul;10(7):669-678. doi: 10.1016/S2213-2600(21)00546-4.
  17. Volpi S, Carnovale V, Colombo C, Raia V, Blasi F, Pappagallo G; PULMOCARE TEAM.
    Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists.
    Health Sci Rep. 2022 Jun 6;5(4):e604. doi: 10.1002/hsr2.604. eCollection 2022 Jul.PMID:35677472.

 

2023

  1. Bezzerri V, Gentili V, Api M, Finotti A, Papi C, Tamanini A, Boni C, Baldisseri E, Olioso D, Duca M, Tedesco E, Leo S, Borgatti M, Volpi S, Pinton P, Cabrini G, Gambari R, Blasi F, Lippi G, Rimessi A, Rizzo R, Cipolli M.
    SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation. Nat Commun. 2023 Jan 10;14(1):132. doi: 10.1038/s41467-023-35862-0.PMID:36627352.
    rif
  2. Conti J, Sorio C, Melotti P.
    Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis.
    Children 2023, 10(1), 4. https://doi.org/10.3390/children10010004.
  3. Lucca F, Bezzerri V, Danese E, Olioso D, Peserico D, Boni C, Cucchetto G, Montagnana M, Tridello G, Meneghelli I, Ros M, Lippi G, Cipolli M.
    Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation.
    Int J Mol Sci. 2023 Jan 4;24(2):908. doi: 10.3390/ijms24020908.PMID:36674422.
  4. Ullmann N, Santamaria F, Allegorico A, Fainardi V, Borrelli M, Ferraro VA, Proietti E, Parisi GF, Romagnoli V, Lucca F, Gallucci M, Mappa L, Lelli M, Amato D, Petrarca L, Cimino G, Sacco O, Calogero C, Patria MF, Acquafredda A, Ferlisi A, Maschio M, Kantar A, Cutrera R.
    Primary ciliary dyskinesia: A multicenter survey on clinical practice and patient management in Italy.
    Pediatr Pulmonol. 2023 Jan 1. doi: 10.1002/ppul.26303. Epub ahead of print. PMID: 36588099.